Quest Diagnostics (NYSE: DGX) is set to acquire select assets of University Hospitals’ outreach laboratory services business in a strategic move aimed at enhancing diagnostic services in Ohio. This acquisition will significantly broaden the access to Quest Diagnostics’ comprehensive test menu, extend its network of patient access sites, and leverage its extensive health plan coverage. […]
Quest Diagnostics (NYSE: DGX), a prominent provider of diagnostic information services, has announced a definitive agreement to acquire LifeLabs, a leading Canadian community laboratory service provider, for approximately CAN $1.35 billion (about USD $985 million), including net debt. This acquisition marks a significant expansion of Quest’s operations into Canada, leveraging over two decades of experience […]
Quest Diagnostics (NYSE: DGX), a premier provider of diagnostic information services, has entered into a definitive agreement to acquire select laboratory assets from Allina Health, a leading non-profit healthcare system. This strategic move aims to enhance the availability and affordability of cutting-edge laboratory services throughout Minnesota and western Wisconsin. The acquisition is poised to benefit […]
Quest Diagnostics, an American diagnostic information services provider, has agreed to acquire early-stage oncology company Haystack Oncology in an all-cash deal worth up to $450 million in a move to add sensitive liquid biopsy technology for enhancing personalized cancer care to its oncology portfolio. Based in Baltimore, Maryland, Haystack Oncology is focused on minimal residual […]